#Obinutuzumab and #Ofatumumab are More Effective Than Rituximab in the Treatment of #MembranousNephropathy Patients With Anti-Rituximab Antibodies #VisualAbstract by Dr Priti MD,FASN🇮🇳 (प्रिति) kireports.org/article/S2468-…

Membranous nephropathy treatment standard doi.org/10.1093/ndt/gf…

Identification of two distinct clusters in membranous lupus nephritis patients: recognition of a high-risk profile based on unsupervised analysis doi.org/10.1093/ndt/gf…

De novo Membranous Nephropathy in Renal Allografts is Associated With #Protocadherin FAT1 doi.org/10.1016/j.ekir… #KIRResearchLetter #MembranousNephropathy

Now open access in NDT Obinutuzumab for the management of immune-mediated glomerular diseases 🧐Obinutuzumab holds significant potential as a novel first-line therapeutic option for various immune-mediated glomerular diseases ▶️academic.oup.com/ndt/article/do…

Presented at #ISNWCN: In the REGENCY trial, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, plus standard therapy provided significantly better renal responses than standard therapy alone in patients with lupus nephritis. Full trial results:

🎇Our new paper in Science Magazine: Kidney Multiome-Based Genetic Scorecard Reveals Convergent Coding and Regulatory Variants. Hongbo Liu science.org/doi/10.1126/sc… 1. Full spectrum of genetic variants related to kidney function (1,000 loci). 2. Comprehensive annotation of

🚨 Breaking down the REGENCY trial 🚨 A Phase 3 RCT evaluating obinutuzumab (Obi) in lupus nephritis (LN). Let's dive into the study design, key findings, and the dosing regimens! 🧵⬇️

Antibody-mediated podocytopathies: a disease entity that implies immunotherapy 🆓doi.org/10.1093/ndt/gf… 📸A proposed diagnostic algorithm in patients with nephrotic syndrome and suspected podocytopathy

Our Yearly #Glomerular Disease Fellows Workshop with #fellows from all over the region coming to learn about glomerular diseases! #Nephrology Penn Kidney

In the Literature by Clara Fischman and Lawrence B. Holzman: Identification of Nephrin Autoantibodies Signals New Chapter for Glomerular Disease bit.ly/3XMpvI6 (FREE) Penn Medicine Original article in NEJM ⬇️

Cardiovascular and Kidney Outcomes of Non-Diabetic CKD by Albuminuria Severity: Findings From the CRIC Study bit.ly/434CTeO Rachel Shulman Debbie Cohen Peter Reese Jordy Cohen, MD, MSCE Penn Kidney Penn Medicine #VisualAbstract

#WhyScience Today, I am launching a 100-day Twitter/X campaign highlighting the importance of science, academia, and academic research in the U.S., with one tweet per day. Please help to increase visibility by liking, retweeting and adding to it.

Great win for AUB Med!🚀🎉A record-breaking 85% match rate in #Match2025—the highest in 8 years! With 122 applicants and 104 matches, both hitting all-time highs, our grads are proving that excellence knows no limits! The future of medicine is brighter than ever! 🔥👩‍⚕️👨‍⚕️

#Corticosteroid Effects in #IgA Nephropathy by Baseline #Proteinuria and Estimated #GFR #VisualAbstract by Pallavi Prasad MD DNB kireports.org/article/S2468-…

The PARASOL Project is expanding its focus to include biomarkers and endpoints in APOL1 kidney disease and primary membranous nephropathy in addition to FSGS. Learn more and get involved: eu1.hubs.ly/H0nr8Lv0 Tobias B. Huber Brad H Rovin patrick nachman Michigan Kidney Translational Med. Center (MiKTMC) Keisha Gibson

Now online in NDT Nephrotoxicity of Non-Platinum Agents and Miscellaneous Nephrotoxic Drugs 🧐Knowing these kidney toxicity profiles is critical to maximize the oncologic benefit while preserving kidney function. ▶️academic.oup.com/ndt/article-ab…

Complement- Kidney biopsy is grossly inadequate when it comes to complement: we stain for only C3/C1q! LMD/MS can: -determine complement pathways -determine burden of complement -Activated vs entrapped complement -Assess complement regulating proteins journals.lww.com/cjasn/abstract…

C3G and Ig-MPGN—treatment standard doi.org/10.1093/ndt/gf…

Congratulations to everyone in the fellowship match! We are thrilled to welcome these wonderful physicians to the Penn Kidney family for #Nephrology #Fellowship in 2026!